Teladoc Health (TDOC) Liabilities and Shareholders Equity (2014 - 2026)

Teladoc Health has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $2.8 billion in Q2 2026.

• Quarterly Liabilities and Shareholders Equity fell 4.68% year-over-year to $2.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.3 billion (down 15.55% YoY) and the FY2025 annual result came in at $2.9 billion, down 18.72% from the prior year.
• Liabilities and Shareholders Equity declined to $2.8 billion in Q2 2026 per TDOC's latest filing, from $2.8 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $11.1 billion in Q1 2022 and troughed at $2.8 billion in Q2 2026.
• A 5-year average of $4.5 billion and a median of $3.9 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity sank 75.5% in 2022, then grew 1.08% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then increased by 1.08% to $4.4 billion in 2023, then decreased by 19.94% to $3.5 billion in 2024, then declined by 18.72% to $2.9 billion in 2025, then declined by 3.49% to $2.8 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.8 billion, $2.8 billion, and $2.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.